Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Datopotamab deruxtecan-based combinations show promising clinical activity in patients with advanced non-small cell lung cancer
-
Tagrisso plus savolitinib demonstrated 49% objective response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial
-
Enhertu approved in the US as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer
-
Calquence tablet formulation approved in the US across current indications
-
Lynparza approved in the EU as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
-
Michel Demaré to succeed Leif Johansson as Non-Executive Chair of the Board
-
H1 2022 results
-
Tezspire recommended for approval in the EU by CHMP for the treatment of severe asthma
-
Ultomiris recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis
-
Enhertu granted Priority Review in the US for patients with HER2-low metastatic breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
